Qurient Co., Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Seongnam-si Korea, Republic of (2008)

Organization Overview

First Clinical Trial
2015
NCT02426359
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Qurient Co., Ltd.